Loading...
•
Jun 30
UHS Q2 2025 Earnings Report
Universal Health Services reported strong Q2 2025 earnings, with revenue and net income rising year-over-year.
Key Takeaways
UHS delivered solid performance in Q2 2025, driven by higher Medicaid reimbursements and growth across both acute and behavioral health segments.
Reported revenue rose to $4.28B, up from $3.91B in Q2 2024.
Net income increased to $353.2M, with EPS at $5.43.
Acute care and behavioral health both saw revenue and patient day growth.
Strong cash position with $137.6M in cash and equivalents at quarter end.
UHS
UHS
UHS Revenue by Segment
Revenue by Segment
Acute Care Services Revenue
CapyFin.comBehavioral Health Revenue
CapyFin.com Forward Guidance
UHS raised its full-year 2025 forecast for revenue, adjusted EPS, and adjusted EBITDA due to improved Medicaid reimbursements and strong performance in core operations.
Positive Outlook
- Increased full-year revenue guidance to $17.096B–$17.312B.
- Raised adjusted EPS guidance to $20.00–$21.00.
- Raised adjusted EBITDA guidance to $2.458B–$2.543B.
- Strong performance from new acute care facility in Washington, D.C.
- Boost from Tennessee and other Medicaid supplemental payment programs.
Challenges Ahead
- Operating cash flow decreased year-over-year.
- Higher interest expenses from prior rate hikes still impacting margins.
- Unfavorable changes in accounts receivable and income tax positions.
- Ongoing litigation risks including Cumberland Hospital.
- Potential revenue headwinds from new Medicaid eligibility restrictions.